Nippon India Nifty Pharma Etf Overview
Category Other ETFs
BMSMONEY Rank 13
BMSMONEY Rating
Gro. Opt. As On: 27-12-2024
NAV ₹23.45(R) +1.3% (D) %
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 38.63% 19.47% -% -% -%
LumpSum (D)
SIP (R) 29.54% 30.96% -% -% -%
SIP (D)
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.7 0.39 0.71 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.32% -18.01% -16.65% - 10.96%
Top Other ETFs
Fund Name Rank Rating
bharat 22 etf 1
cpse etf 2
Nippon India ETF Nifty Dividend Opportunities 50 3
Uti Nifty Next 50 Exchange Traded Fund 4
Aditya Birla Sun Life Nifty Healthcare ETF 5
UTI BSE Sensex Next 50 Exchange Traded Fund 6
Nippon India Etf Nifty Midcap 150 7
SBI BSE Sensex Next 50 ETF 8
Motilal Oswal Nifty Midcap 100 ETF 9
Icici Prudential Nifty Next 50 Etf 10
mirae asset nifty next 50 etf 11
kotak nifty 50 value 20 etf 12
Nippon India Nifty Pharma ETF 13
ICICI Prudential Nifty Healthcare ETF 14
SBI Nifty Next 50 ETF 15
Mirae Asset NYSE FANG+ ETF 16
Nippon India ETF BSE Sensex Next 50 17

NAV Date: 27-12-2024

Scheme Name NAV Rupee Change Percent Change
Nippon India Nifty Pharma ETF 23.45
0.3000
1.3000%

Review Date: 27-12-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed five return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: Five return parameters of the Nippon India Nifty Pharma ETF are in the top 25% in the category, as listed below:
      • 1M Return %
      • 3M Return %
      • 6M Return %
      • 1Y Return %
      • 3Y Return %
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Nippon India Nifty Pharma ETF has no return parameters that are below average in the category.
  2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For Nippon India Nifty Pharma ETF, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Nippon India Nifty Pharma ETF does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Nifty Pharma ETF does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Nippon India Nifty Pharma ETF has two parameters that are above average which are listed below:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 16.32 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.96 %.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated three risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: Nippon India Nifty Pharma ETF has two risk-adjusted performance parameters of the fund that are in the top 25% of the category.
      • Sharpe Ratio: Nippon India Nifty Pharma ETF has a Sharpe Ratio of 0.7 compared to the category average of 0.45.
      • Sortino Ratio: Nippon India Nifty Pharma ETF has a Sortino Ratio of 0.39 compared to the category average of 0.21.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: Nippon India Nifty Pharma ETF has one risk-adjusted performance parameter of the fund that is in the this group of the category.
      • Sterling Ratio: Nippon India Nifty Pharma ETF has a Sterling Ratio of 0.71 compared to the category average of 0.68.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 5.38
-0.83
-7.70 | 10.68 2 | 185 Very Good
3M Return % -2.20
-5.74
-16.97 | 20.83 42 | 185 Very Good
6M Return % 18.20
1.90
-11.08 | 30.39 19 | 182 Very Good
1Y Return % 38.63
8.89
-89.91 | 56.19 6 | 166 Very Good
3Y Return % 19.47
6.69
-50.51 | 42.92 16 | 102 Very Good
1Y SIP Return % 29.54
8.16
-39.91 | 50.29 19 | 159 Very Good
3Y SIP Return % 30.96
17.68
-7.36 | 48.17 10 | 94 Very Good
Standard Deviation 16.32
13.63
0.00 | 28.07 59 | 82 Average
Semi Deviation 10.96
9.40
0.00 | 18.70 56 | 82 Average
Max Drawdown % -16.65
-11.90
-35.55 | 0.00 71 | 82 Poor
VaR 1 Y % -18.01
-15.87
-34.01 | 0.00 56 | 82 Average
Average Drawdown % -6.77
-5.73
-16.35 | 0.00 63 | 82 Average
Sharpe Ratio 0.70
0.45
-0.79 | 1.91 19 | 79 Very Good
Sterling Ratio 0.71
0.68
0.00 | 2.26 27 | 82 Good
Sortino Ratio 0.39
0.21
-1.00 | 1.24 18 | 82 Very Good
Return data last Updated On : Dec. 27, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 16.32 13.63 0.00 | 28.07 59 | 82
Semi Deviation 10.96 9.40 0.00 | 18.70 56 | 82
Max Drawdown % -16.65 -11.90 -35.55 | 0.00 71 | 82
VaR 1 Y % -18.01 -15.87 -34.01 | 0.00 56 | 82
Average Drawdown % -6.77 -5.73 -16.35 | 0.00 63 | 82
Sharpe Ratio 0.70 0.45 -0.79 | 1.91 19 | 79
Sterling Ratio 0.71 0.68 0.00 | 2.26 27 | 82
Sortino Ratio 0.39 0.21 -1.00 | 1.24 18 | 82
Return data last Updated On : Dec. 27, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 1.30 ₹ 10,130.00 ₹
1W 2.25 ₹ 10,225.00 ₹
1M 5.38 ₹ 10,538.00 ₹
3M -2.20 ₹ 9,780.00 ₹
6M 18.20 ₹ 11,820.00 ₹
1Y 38.63 ₹ 13,863.00 ₹
3Y 19.47 ₹ 17,053.00 ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 29.54 ₹ 13,843.19 ₹
3Y ₹ 36000 30.96 ₹ 56,087.86 ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth
27-12-2024 23.4493 None
26-12-2024 23.1482 None
24-12-2024 22.9919 None
23-12-2024 23.0055 None
20-12-2024 22.9343 None
19-12-2024 23.1341 None
18-12-2024 22.7437 None
17-12-2024 22.4993 None
16-12-2024 22.6838 None
13-12-2024 22.5841 None
12-12-2024 22.6576 None
11-12-2024 22.7324 None
10-12-2024 22.7211 None
09-12-2024 22.7392 None
06-12-2024 22.8676 None
05-12-2024 22.8968 None
04-12-2024 22.8557 None
03-12-2024 22.8791 None
02-12-2024 22.8838 None
29-11-2024 22.6702 None
28-11-2024 22.1491 None
27-11-2024 22.2511 None

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.